Geno.Me lands $400,000 in seed funding from Gateway Capital

WisBiz 2

A biotech startup called Geno.Me has landed $400,000 in seed funding from Gateway Capital, an early-stage investment firm based in Milwaukee.

The company’s platform connects electronic health record data with genomic information from services like 23andMe, MyChart and in hopes of furthering medical research. Individuals who share their data with the platform are compensated on a monthly basis, while the business promises them total privacy and anonymity. 

These linked datasets are encrypted and sold to companies conducting precision health research and developing pharma...

Please log in to access subscriber content.
If you don't have a subscription, click here for a WisPolitics free trial and to view the different subscription options.

Upcoming Events